Phenamil, an analog of amiloride, is a potent blocker of the epithelial Na' channel. It has been used to purify the porcine kidney amiloride-binding protein. analogs with affinities similar to the amiloride receptor associated with the apical Na+ channel in pig kidney membranes and (it) that is immunoprecipitated with monoclonal antibodies raised against pig kidney amiloride-binding protein.
protein is 713 residues long, with a 19-amino acid signal peptide. The mRNA was expressed in 293-S and NIH 3T3 cells, yielding a glycoprotein (t) that binds amiloride and amiloride analogs with affinities similar to the amiloride receptor associated with the apical Na+ channel in pig kidney membranes and (it) that is immunoprecipitated with monoclonal antibodies raised against pig kidney amiloride-binding protein.
High-resistance epithelia actively transport Na+ from the luminal side to the blood. Regulation of the Na+ transport activity is an important component of salt and fluid homeostasis. Na+ transport is controlled by hormones and blocked by amiloride (1) . Amiloride is an important diuretic drug that has a dual action on Na+ transport by the kidney. It blocks a Na+/H+ exchange system (2) and a Na+-selective ionic channel (3) that are located in the proximal and distal parts of the tubule, respectively. Amiloride derivatives such as phenamil and benzamil are potent blockers of apical Na+ channels at concentrations at which they have very little (if any) activity on the Na+/H+ exchanger (4, 5 (6, 7) . It is composed of two apparently identical and disulfide-bonded subunits of about 100 kDa.
This paper describes (i) the isolation of the human kidney ABP cDNA and the primary structure of the corresponding protein and (ii) the successful expression of this cDNA in transfected mammalian cells.l
MATERIALS AND METHODS
Protein Purification and Amino Acid Sequence Analysis. ABP was isolated from frozen pig kidneys as described (7); 1.5 nmol of the purified peptide was used for preparative sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) on an isocratic 7.5% running gel (8) . The receptor was electroeluted according to ref. 9 and then concentrated by partial lyophilization. After removal of SDS (10) , ABP (35 ,ug) was redissolved in 50 ,ul of 0.5 M urea. The protein sample was then digested for 30 hr with 5 ,ug of L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin in two steps at 37°C under argon.
Tryptic peptides were separated by HPLC using an analytical RP300 5-A column of 1-mm diameter (Brownlee) equilibrated in water containing 0.1% triethylamine, 0.05% trifluoroacetic acid, and 0.001% 2-mercaptoethanol. Elution was performed in 6 hr with a linear gradient of acetonitrile from 0 to 90%o at a flow rate of 80 ,ul/min. Fractions were collected in Pico-Tag glass tubes following the absorbance at 214 nm. Edman degradation was performed with an Applied Biosystems 470A microsequencer, and phenylthiohydantoinamino acids were identified using an on-line analyzer (Applied Biosystems 120A).
For determination of the N-terminal sequence of ABP, 100-150 pmol of the receptor was submitted to SDS/PAGE analysis. The protein was then transferred onto Polybrenecoated glass fiber sheet by electroblotting (11) and submitted to Edman degradation.
Cloning and Sequencing of the Receptor. AgtlO cDNA libraries were constructed using human adult kidney mRNA as described (12) . Initial cDNA clones were identified with a synthetic oligonucleotide based on the sequence of tryptic fragment 3 ( Fig. 1 ) and codon frequency statistics (13) . The oligonucleotide sequence was 5'-ACCACAGGCTCCTCCT-TTGGCGATGAGCATGAGCAGGAGCTGACCTTCACA-GATGTGGCCCCCCGG-3'. The cDNA insert [500 base pairs (bp)] of the first isolated ABP clone was used in subsequent screening.
Single-stranded DNAs were sequenced by the dideoxy chain-termination method (14) . Sequence data were aligned, decoded, and examined using BISANCE sequence analysis programs (C.I.T.I.2 Paris), including programs for hydropathy and secondary structure analysis (15) (16) (17) and searches in the National Biomedical Research Foundation (release 22) and GenBank (release 61) data bases.
Transfection of the cDNA into Eukaryotic Cell Lines. The complete 2.4-kilobase (kb) cDNA insert was ligated into the cloning site of the mammalian expression vector pRK5, cotransfected with a plasmid containing the neomycin resistance gene into human 293-S and NIH 3T3 cells using the calcium phosphate technique (18) , and then selected for resistance to G418 at 500 pAg/ml. Neomycin (Fig. 1A, lane a) . After an electroelution step, the receptor (Fig. 1A , lane b) was digested with trypsin. Fig. 1B shows a typical separation of tryptic peptides. Several well-separated peaks (from two independent experiments) yielded unambiguous sequence information shown in Fig. 1 . Synthetic oligodeoxyribonucleotides were prepared on the basis of these partial sequences (13) . Screening of a 5 x 105-clone cDNA library from human adult kidney in AgtlO with a 66-nucleotide-long probe derived from the tryptic peptide 3 resulted in four identical 500-bp clones that contained the expected ABP sequence. The isolated cDNA fragment was subsequently used for screening 1.5 million clones of the second cDNA library. Twelve recombinant phage of about 50 hybridizing positives were analyzed and the two largest cDNA inserts (about 2.4 kbp) were subjected to nucleotide sequence analysis. The two clones (named ABP1 and ABP2) were essentially identical but the ABP2 clone was 29 bp longer on the 5' end.
ABP cDNA Coding Sequence. Fig. 2 shows the 2396-nucleotide sequence of the cDNA encoding the phenamil receptor from human kidney. The initiation site was assigned to the methionine codon composed of nucleotide residues 1-3 because it is the first ATG triplet that flanks functional initiation codons (21) . There is an open reading frame of 713 codons. The different peptides characterized by microsequencing of porcine ABP were identified within the deduced human ABP amino acid sequence. The few sequence differences are probably due to species differences (Fig. 1) .
The N-terminal sequence of porcine ABP identified by Edman degradation is Glu-Pro-Ser-Pro. This sequence appears at residue 20 (Fig. 2) . It is situated after a hydrophobic 19 -amido acid stretch that shows all of the typical features of a signal sequence (22 3), in good agreement with the length of the insert that has been characterized. From the cDNA sequence, one can then conclude that human ABP is composed of 694 amino acid residues once the signal peptide has been released. The calculated molecular mass of the mature peptide is 78,886 daltons. There are three potential N-glycosylation sites at residues 110, 168, and 536.
RNA blot patterns presented in Fig. 3 indicate that ABP mRNA from mouse and pig kidneys have sizes that are substantially larger (4.4 kb and 3.3 kb, respectively) than those of human ABP mRNA (2.4 kb). gcgaactgggagcagaggcacacagagccgtggagcgagag -1 RTE CCG GCC CTG GGC TOG GCC GTG OCT GCC RTC CTG RTG CTG CRG ACG GCC ATG 51
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RCA CCT GOO ARC TCC GTO GGC TTC CTG CTC CGC CCR TTC ARC TTC TTC CCR GRC 2106 (Fig. 4B ) and dissociation (Fig. 4C) Sizing of kidney ABP mRNAs from different species. mRNA samples from murine, human, and porcine kidneys were subjected to electrophoresis on a 1.2% agarose gel (23) . After electrophoresis, the RNAs were blotted to nitrocellulose paper and hybridized with a phosphorylated 73-mer probe at 420C for 15 hr. Sizes of RNA markers are indicated. revealed a single peptide at 97 kDa (Fig. 5, lanes c and e) . Under nonreduced conditions, the protein migrated at about 180 kDa (not shown). These properties are identical to those of the purified ABP from pig kidney. In 293-S cells, the half-life of ABP biosynthesis was about 30 min.
ABP is a glycoprotein (7) . The extent of glycosylation was investigated by treating cells for 16 hr with 20 ,ug of tunicamycin per ml, an inhibitor of the N-glycosylation process. This treatment led to the disappearance of the 97-kDa peptide and to its replacement by a 70-kDa species (Fig. 5, lanes d and f) .
Protein Structure. The primary structure of the ABP has no sequence homology with any known protein, including the previously cloned receptors or ionic channels. The protein is rich in prolines (64 prolines in 713 residues-i.e., 9% of the total amino acids), especially in two regions. A first region, between Cys-267 and Pro-326, is composed of 22% prolines (13/60) and contains 7% cysteines. Negative residues (Asp and Glu) are underrepresented in this part of the sequence, which has a large positive charge at physiological pH. This domain is largely hydrophilic. A high density of prolines is also observed (12/72 = 16%) in the C-terminal domain (from Pro641 to Leu713), in which basic residues (Lys, Arg, and His) are rare and which has a large negative charge at physiological pH. The hydropathicity profile is not similar to that of membrane-spanning proteins, which usually display numerous hydrophobic helices (not shown).
Although transfection experiments have clearly shown the existence of a well-characterized amiloride/phenamilbinding protein in the cell membrane fraction, no amiloridesensitive Na' channel activity was observed using patchclamp techniques in transfected cells (not shown). Moreover, although George et al. (25) require other distinct protein subunits for functional expression. Benos et al. (26) have suggested that the apical Na' channel present in a Xenopus kidney cell line (A6) is a multisubunit assembly of 315-, 149-, 95-, 71-, 55-, and 35-kDa peptides. The amiloride-binding component and the channel subunit might be distinct. Since it has been previously shown (7) that reconstitution of purified ABP displays 22Na+ transport activity, such an interpretation would suggest that other subunits present in the purified material were not detected on gels but are important in the Na+ transport activity.
Another interpretation for the absence of channel activity in transfected cells would be that alternative splicing has removed a short but important transmembrane protein segment that would be essential for Na+ channel function. A similar situation has been recently observed for the human interleukin 7 receptor (27) .
Numerous subtypes of voltage-dependent ion channels and of ion channels coupled to neurotransmitter receptors have been identified (28) . Similarly, there is a family of subtypes of amiloride-sensitive Na' channels that slightly differ by their conductance, their ionic selectivity, and their affinities for amiloride and its analogs. Amiloride-sensitive Na' channels are important for kidney function but they are also present in frog skin (29) , in urinary bladder (30) , in thyroid cells (31) , in blood-brain barrier endothelial cells (32) , and in colonic enterocytes (33) . They have a role in sensory perception. Amiloride-blockable Na+ channels seem to provide the transducer mechanism for the "salty" taste (34) and for the response to odorants of receptor cells in the nasal mucosa (35) .
Amiloride-sensitive Na+ channels are present in airway epithelia, where they play an important role in fluid secretion (36) . Amiloride inhibits the excessive absorption of Na+ and liquid that takes place in airway epithelia of patients with cystic fibrosis (CF) (37) , and amiloride aerosol therapy is being tried for the treatment of lung disease in CF (38) . It turns out that we have recently observed that the structural gene for ABP is situated on human chromosome 7 in a region that flanks the CF locus (39) .
